Globestar Therapeutics's ROI from its third quarter of 2024 to the third quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Globestar Therapeutics's ROI in the third quarter of 2024?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Globestar Therapeutics Corporation's return on investment (ROI) in its third quarter of 2024

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2024) III. Quarter	(Mar 31 2024) II. Quarter	(Dec 31 2023) I. Quarter	(Sep 30 2023) IV. Quarter	(Jun 30 2023) III. Quarter
Y / Y Investment Change TTM	-	-	-	-	-
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	-2	-1	-2	-1	-1
Return On Investment (TTM)	-	-	-	-	-
GSTC's Overall Ranking	#	#	#	#	#
Seq. Investment Change TTM	-	-	-	-	-
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-1	-2	-2	-2	-2

GSTC Company Profile >> Back to GSTC Roi Comparisons >> See Annual GSTC Return On Investment

Return On Investment GSTC's Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Investment Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Globestar Therapeutics's III. Quarter Investments	$ -2 Millions	GSTC's Balance sheet
Globestar Therapeutics's III. Quarter Income	$ 0 Millions	Quarterly GSTC's Income Statement
GSTC's Income by Division		See GSTC's Income by Division

GSTC Annual Return On Investment	(Sep 30 2023) 2023	(Sep 30 2022) 2022
Total Investments in Millions	-1	-1	-1	0	-1
Y / Y Investment Growth	-	-	-	-	-
Net Income in Millions	-2	-1	0	0	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-	-	-	-	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
GSTC's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for GSTC's Competitors
Subscribers only: Roi for Globestar Therapeutics's Suppliers
Subscribers only: Return On Investment for GSTC's Customers

Other Ratios
GSTC's Roa	GSTC's Inventory Turnover Ratio	GSTC's Growth Rates	GSTC's Dividend Statistics
	GSTC's Profitability Ratios	GSTC's Asset Turnover Ratio	GSTC's Dividend Growth
GSTC's Roe	GSTC's Valuation Ratios	GSTC's Financial Strength Ratios	GSTC's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2024, within Healthcare Sector	ROI
Alaunos Therapeutics Inc	152.92 %
Camp4 Therapeutics Corporation	84.34 %
Roivant Sciences Ltd	77.20 %
Earth Science Tech Inc	73.25 %
Mimedx Group Inc	57.35 %
Guardion Health Sciences Inc	55.97 %
Biomx Inc	52.39 %
Entrada Therapeutics Inc	50.42 %
Siga Technologies Inc	50.32 %
Dariohealth Corp	50.05 %
Entera Bio Ltd	48.24 %
Scienture Holdings Inc	43.00 %
Protagonist Therapeutics inc	37.74 %
Mettler toledo International Inc	36.92 %
Medpace Holdings Inc	36.84 %
Valion Bio Inc	36.78 %
Nrc Health	36.51 %
Idexx Laboratories Inc	36.50 %
Pharmacyte Biotech Inc	36.30 %
Elite Pharmaceuticals Inc	33.34 %
Exelixis Inc	32.02 %
Johnson and Johnson	30.31 %
Sbc Medical Group Holdings Incorporated	28.61 %
Lantheus Holdings Inc	28.19 %
Cyclerion Therapeutics Inc	28.07 %
Lite Strategy Inc	27.58 %
Carlisle Companies Incorporated	25.54 %
Cytomx Therapeutics Inc	25.09 %
Iradimed Corporation	23.73 %
Corcept Therapeutics Inc	23.22 %

Date modified: 2026-09-08T15:11:19+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.